SSIFT is a recently developed MRI method that provides a specific means to detect brain tumors based on their differences in cell size. However, to date SSIFT has not been adequately validated. We therefore used computer simulations and studies of cultured cells in vitro and animal models in vivo to comprehensively validate SSIFT for brain cancer imaging. The results suggest SSIFT is highly specific for cell size and can differentiate brain tumors from other brain abnormalities such as peri-tumor edema and radiation necrosis, which cannot be reliably distinguished by other current MRI methods.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords